We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

21 hedge funds and large institutions have $33.1M invested in Redhill Biopharma in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less funds holding

Funds holding: 22 → 21 (-1)

10% less capital invested

Capital invested by funds: $36.9M → $33.1M (-$3.82M)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
21
Holders Change
-1
Holders Change %
-4.55%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$174K
2
Walleye Trading
Walleye Trading
New York
+$37.3K
3
VanEck Associates
VanEck Associates
New York
+$12.4K

Top Sellers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
-$3.48M
2
BHB
Bank Hapoalim BM
Israel
-$224K
3
Millennium Management
Millennium Management
New York
-$178K
4
SM
Sabby Management
Florida
-$174K
5
FAM
Fred Alger Management
New York
-$99.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
– -$3K – –
Northwestern Mutual Wealth Management
27
Northwestern Mutual Wealth Management
Wisconsin
– -$4K – –
1
2

RDHL Hedge Fund Activity: Q4 2015 in Review

21 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q4 2015, worth a combined $33.1M — down 10% from $36.9M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of RDHL and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 2 added.

The largest buyer was Morgan Stanley, adding an estimated $174K. The largest seller was AWM Investment Company, exiting entirely with an estimated $3.48M sold.

  • 21 institutional investors held Redhill Biopharma (RDHL) as of Q4 2015, down from 22 in Q3 2015.
  • Funds reported $33.1M of Redhill Biopharma stock for Q4 2015, down 10% quarter-over-quarter.
  • 2 funds opened new Redhill Biopharma positions in Q4 2015 and 3 closed out, a net change of -1 holder.
  • The largest Redhill Biopharma buyer in Q4 2015 was Morgan Stanley, an estimated $174K added.
  • The largest Redhill Biopharma seller in Q4 2015 was AWM Investment Company, an estimated $3.48M sold.

Based on aggregated 13F filings for Q4 2015.